Join to View Full Profile
1240 Lee StCharlottesville, VA 22908
Phone+1 434-924-9333
Fax+1 434-244-7526
Dr. Dreicer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1986 - 1989
Indiana University School of MedicineResidency, Internal Medicine, 1983 - 1986
McGovern Medical School at UTHealthClass of 1983
Certifications & Licensure
CA State Medical License 2002 - Present
VA State Medical License 2015 - 2026
OH State Medical License 1999 - 2017
NY State Medical License 2002 - 2016
PA State Medical License 2002 - 2016
MI State Medical License 2002 - 2015
IL State Medical License 2002 - 2005
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- First-in-human Study of CCW702 in Patients With Metastatic Castration Resistant Prostate Cancer Start of enrollment: 2020 Jul 17
Publications & Presentations
PubMed
- Incidental Brain Metastases From Prostate Cancer Diagnosed With PSMA PET/CT and MRI: A Case Series and Literature Review.Mark Willy L Mondia, Prem P Batchala, Robert Dreicer, Michael E Devitt, Matthew R McCord
The Prostate. 2025-03-13 - COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts.Sumanta K Pal, Yohann Loriot, Andrea Necchi, Parminder Singh, Daniel Castellano
Journal of Clinical Oncology. 2025-02-18 - 1 citationsImpact of Renin-Angiotensin System Inhibitors on Response to PD1/L1 Inhibitors in Patients With Metastatic Renal Cell Carcinoma.Kathryn Fortune, Soham Ali, Jack Masur, Paul Viscuse, Michael Devitt
Clinical Genitourinary Cancer. 2025-02-01
Press Mentions
Panel Issues New Guidelines for Advanced Prostate CancerJanuary 13th, 2025- Radiopharmaceuticals in Prostate Cancer: Key Considerations and New DevelopmentsJanuary 9th, 2025
- Prostate Cancer Death Risk Varies by Histologic SubtypeAugust 23rd, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
